Unknown PHASE4 INTERVENTIONAL 2-arm NCT03433586

COMT on Aspirin Platelets Effects (CAPE) (CAPE)

Sponsor: Brigham and Women's Hospital

Updated 9 times since 2018 Last updated: Jun 23, 2021 Started: Jul 10, 2020 Primary completion: Jan 30, 2022 Completion: Apr 30, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03433586, this PHASE4 trial focuses on Cardiovascular Diseases and remains ongoing. Sponsored by Brigham and Women's Hospital, it has been updated 9 times since 2020, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jul 2023 — Jul 2024 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Sep 2021 — Jul 2023 [monthly]

Recruiting PHASE4
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting · Phase: NA → PHASE4

▶ Show 4 earlier versions

Apr 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA
Jun 2018 — Apr 2019 [monthly]

Not Yet Recruiting NA
May 2018 — Jun 2018 [monthly]

Not Yet Recruiting NA
Mar 2018 — May 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Brigham and Women's Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Data source: Brigham and Women's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States